Aynacioglu A Sükrü, Nacak Muradiye, Filiz Ayten, Ekinci Erhan, Roots Ivar
Department of Pharmacology, Faculty of Medicine, University of Pamukkale, Denizli, Turkey.
Br J Clin Pharmacol. 2004 Feb;57(2):213-7. doi: 10.1046/j.1365-2125.2003.01975.x.
Glutathione S-transferase P1 (GSTP1), the abundant isoform of glutathione S-transferases (GSTs) in lung epithelium, plays an important role in cellular protection against oxidative stress and toxic foreign chemicals. It has been suggested that polymorphisms in the GSTP1 gene are associated with asthma and related phenotypes. As significant interindividual and interethnic differences exist in the distribution of xenobiotic-metabolizing enzymes, we have studied the GSTP1 Ile105Val polymorphism in patients with asthma in a Turkish sample.
GSTP1 Ile105Val polymorphism in exon 5 was determined in 210 patients with asthma (112 extrinsic and 108 intrinsic) and 265 control individuals without lung diseases and without history of allergy or atopy, using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) techniques.
The proportion of GSTP1 Val105 homozygotes was significantly lower in the patients with asthma than in the control individuals (3.8% vs 12.1%). The odds ratio for GSTP1 Val105 homozygotes vs all other genotypes was 0.29 (95%CL 0.13-0.64, p = 0.01) for asthmatics. The distribution of GSTP1 Ile105Val genotypes and the frequency of GSTP1 Val105Val homozygotes (3.7% vs 3.9%) was not significantly different between extrinsic and intrinsic asthmatics.
These results suggest a significant association between GSTP1 Ile105Val polymorphism and susceptibility to asthma and that the GSTP1 Val105Val genotype may be protective against developing this disease.
谷胱甘肽S-转移酶P1(GSTP1)是肺上皮细胞中谷胱甘肽S-转移酶(GSTs)的主要同工型,在细胞抵御氧化应激和有毒外来化学物质方面发挥重要作用。有人提出,GSTP1基因多态性与哮喘及相关表型有关。由于外源性代谢酶的分布存在显著的个体间和种族间差异,我们在一个土耳其样本中研究了哮喘患者的GSTP1 Ile105Val多态性。
采用聚合酶链反应(PCR)-限制性片段长度多态性(RFLP)技术,对210例哮喘患者(112例过敏性哮喘和108例非过敏性哮喘)以及265例无肺部疾病、无过敏或特应性病史的对照个体进行外显子5中GSTP1 Ile105Val多态性的检测。
哮喘患者中GSTP1 Val105纯合子的比例显著低于对照个体(3.8%对12.1%)。哮喘患者中GSTP1 Val105纯合子与所有其他基因型相比的优势比为0.29(95%置信区间0.13 - 0.64,p = 0.01)。过敏性哮喘和非过敏性哮喘患者之间GSTP1 Ile105Val基因型的分布以及GSTP1 Val105Val纯合子的频率(3.7%对3.9%)无显著差异。
这些结果表明GSTP1 Ile105Val多态性与哮喘易感性之间存在显著关联,并且GSTP1 Val105Val基因型可能对该疾病的发生具有保护作用。